472 related articles for article (PubMed ID: 18980797)
21. Interventional stroke therapy: the potential benefit of direct intra-arterial infusion.
Connors JJ
Rev Cardiovasc Med; 2002; 3 Suppl 2():S92-9. PubMed ID: 12556748
[TBL] [Abstract][Full Text] [Related]
22. Thrombolysis for ischemic stroke in the United States: data from National Hospital Discharge Survey 1999-2001.
Qureshi AI; Suri MF; Nasar A; He W; Kirmani JF; Divani AA; Prestigiacomo CJ; Low RB
Neurosurgery; 2005 Oct; 57(4):647-54; discussion 647-54. PubMed ID: 16239876
[TBL] [Abstract][Full Text] [Related]
23. Activation of plasma procarboxypeptidase U in different mammalian species points to a conserved pathway of inhibition of fibrinolysis.
Schatteman KA; Goossens FJ; Scharpé SS; Hendriks DF
Thromb Haemost; 1999 Dec; 82(6):1718-21. PubMed ID: 10613660
[TBL] [Abstract][Full Text] [Related]
24. Inhibition of carboxypeptidase U (TAFIa) activity improves rt-PA induced thrombolysis in a dog model of coronary artery thrombosis.
Björkman JA; Abrahamsson TI; Nerme VK; Mattsson CJ
Thromb Res; 2005; 116(6):519-24. PubMed ID: 16181987
[TBL] [Abstract][Full Text] [Related]
25. Antithrombotic and thrombolytic therapy for ischemic stroke.
Ocava LC; Singh M; Malhotra S; Rosenbaum DM
Clin Geriatr Med; 2006 Feb; 22(1):135-54, ix-x. PubMed ID: 16377471
[TBL] [Abstract][Full Text] [Related]
26. Carboxypeptidase U (TAFIa): a metallocarboxypeptidase with a distinct role in haemostasis and a possible risk factor for thrombotic disease.
Leurs J; Hendriks D
Thromb Haemost; 2005 Sep; 94(3):471-87. PubMed ID: 16268459
[TBL] [Abstract][Full Text] [Related]
27. Procarboxypeptidase U (TAFI) contributes to the risk of thrombosis in patients with hereditary thrombophilia.
Heylen E; Miljic P; Willemse J; Djordjevic V; Radojkovic D; Colovic M; Elezovic I; Hendriks D
Thromb Res; 2009 Sep; 124(4):427-32. PubMed ID: 19195685
[TBL] [Abstract][Full Text] [Related]
28. Selective inhibition of carboxypeptidase U may reduce microvascular thrombosis in rat experimental stroke.
Mertens JC; Boisseau W; Leenaerts D; Di Meglio L; Loyau S; Lambeir AM; Ducroux C; Jandrot-Perrus M; Michel JB; Mazighi M; Hendriks D; Desilles JP
J Thromb Haemost; 2020 Dec; 18(12):3325-3335. PubMed ID: 32869423
[TBL] [Abstract][Full Text] [Related]
29. Spinal epidural hematoma after intravenous thrombolysis for acute ischemic stroke.
Yeo LL; Lim JS; Sharma VK
J Neurol Sci; 2009 Sep; 284(1-2):190-1. PubMed ID: 19411083
[TBL] [Abstract][Full Text] [Related]
30. Treatment of acute ischemic stroke: intravenous and endovascular therapies.
Jahan R; Vinuela F
Expert Rev Cardiovasc Ther; 2009 Apr; 7(4):375-87. PubMed ID: 19379062
[TBL] [Abstract][Full Text] [Related]
31. Acute changes of coagulation and fibrinolysis parameters after experimental thromboembolic stroke and thrombolytic therapy.
Stehling F; Weber R; Ozcelik A; Bröcker M; Volbracht L; Diener HC; Busch E
Neurosci Lett; 2008 Aug; 441(1):39-43. PubMed ID: 18597942
[TBL] [Abstract][Full Text] [Related]
32. QT dispersion in patients with acute ischemic stroke who underwent thrombolytic treatment: is it really useful to predict good neuorologic recovery?
Celik T; Iyisoy A; Bugan B; Isik E
Int J Cardiol; 2008 Apr; 125(2):290-1. PubMed ID: 18190979
[TBL] [Abstract][Full Text] [Related]
33. ST-elevation myocardial infarction associated with acute ischemic stroke.
Patanè S; Marte F; Lentini C; Buonamonte S
Int J Cardiol; 2010 Dec; 145(3):e116-8. PubMed ID: 20110132
[TBL] [Abstract][Full Text] [Related]
34. Lower pretreatment cerebral blood volume affects hemorrhagic risks after intra-arterial revascularization in acute stroke.
Bhatt A; Vora NA; Thomas AJ; Majid A; Kassab M; Hammer MD; Uchino K; Wechsler L; Jovin TG; Gupta R
Neurosurgery; 2008 Nov; 63(5):874-8; discussion 878-9. PubMed ID: 19005377
[TBL] [Abstract][Full Text] [Related]
35. Third generation thrombolytics for the treatment of ischemic stroke.
Qureshi AI; Pande RU; Kim SH; Hanel RA; Kirmani JF; Yahia AM
Curr Opin Investig Drugs; 2002 Dec; 3(12):1729-32. PubMed ID: 12528307
[TBL] [Abstract][Full Text] [Related]
36. The only evidence based neuroprotective therapy for acute ischemic stroke: thrombolysis.
Köhrmann M; Schellinger PD; Schwab S
Best Pract Res Clin Anaesthesiol; 2010 Dec; 24(4):563-71. PubMed ID: 21619867
[TBL] [Abstract][Full Text] [Related]
37. Influence of antiplatelet pre-treatment on the risk of symptomatic intracranial haemorrhage after intravenous thrombolysis.
Bravo Y; Martí-Fàbregas J; Cocho D; Rodríguez-Yáñez M; Castellanos M; de la Ossa NP; Roquer J; Obach V; Maestre J; Martí-Vilalta JL
Cerebrovasc Dis; 2008; 26(2):126-33. PubMed ID: 18560215
[TBL] [Abstract][Full Text] [Related]
38. Development of a sensitive and selective assay for the determination of procarboxypeptidase U (thrombin-activatable fibrinolysis inhibitor) in plasma.
Heylen E; Van Goethem S; Willemse J; Olsson T; Augustyns K; Hendriks D
Anal Biochem; 2010 Jan; 396(1):152-4. PubMed ID: 19732738
[TBL] [Abstract][Full Text] [Related]
39. Ancrod for acute ischemic stroke: a new dosing regimen derived from analysis of prior ancrod stroke studies.
Levy DE; Trammel J; Wasiewski WW;
J Stroke Cerebrovasc Dis; 2009 Jan; 18(1):23-7. PubMed ID: 19110140
[TBL] [Abstract][Full Text] [Related]
40. [Combined intraarterial thrombolysis and intra-cerebral stent for acute ischemic stroke institute of brain vascular diseases].
Li SM; Miao ZR; Zhu FS; Wang ML; Hua Y; Dong Y; Song QB; Ling F
Zhonghua Yi Xue Za Zhi; 2003 Jan; 83(1):9-12. PubMed ID: 12757636
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
